Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Helping folks find the best TVs for their living spaces is one of the best parts of my day ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...